Comparative genomics analysis of Stenotrophomonas maltophilia strains from a community
Frontiers in Cellular and Infection Microbiology · 28.11.2023 · 13
DOI: 10.3389/fcimb.2023.1266295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.11.2023. Verfasst von Yini Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Affiliated Hospital of Southwest Medical University, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Anti-Infective Agents, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Stenotrophomonas maltophilia is a multidrug-resistant (MDR) opportunistic pathogen with high resistance to most clinically used antimicrobials. The dissemination of MDR S. maltophilia and difficult treatment of its infection in clinical settings are global issues.
Methods
To provide more genetic information on S. maltophilia and find a better treatment strategy, we isolated five S. maltophilia , SMYN41–SMYN45, from a Chinese community that were subjected to antibiotic susceptibility testing, biofilm formation assay, and whole-genome sequencing. Whole-genome sequences were compared with other thirty-seven S. maltophilia sequences.
Results
The five S. maltophilia strains had similar antibiotic resistance profiles and were resistant to β-lactams, aminoglycosides, and macrolides. They showed similar antimicrobial resistance (AMR) genes, including various efflux pumps, β-lactamase resistance genes ( blaL1/2 ), aminoglycoside resistance genes [ aac(6’) , aph(3’/6) ], and macrolide-resistant gene ( MacB ). Genome sequencing analysis revealed that SMYN41-SMYN45 belonged to sequence type 925 (ST925), ST926, ST926, ST31, and ST928, respectively, and three new STs were identified (ST925, ST926, and ST928).
Conclusion
This study provides genetic information by comparing genome sequences of several S. maltophilia isolates from a community of various origins, with the aim of optimizing empirical antibiotic medication and contributing to worldwide efforts to tackle antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Affiliated Hospital of Southwest Medical University, Southwest Medical University, Luzhou, China.
- Department of Pathogen Biology, School of Basic Medicine, Public Center of Experimental Technology of Pathogen Biology Technology Platform, Southwest Medical University, Luzhou, China.
- Laboratory Animal Center, Southwest Medical University, Luzhou, China.
- Department of Allergy, Jiangnan University Medical Center, Wuxi, China.
- Affiliated Hospital of Southwest Medical University, Southwest Medical University, Luzhou, China.
Zitieren
APA
Li, Y., Liu, X., Chen, L., Shen, X., Wang, H., Guo, R., Li, X., Yu, Z., Zhang, X., Zhou, Y., & Fu, L. (2023). Comparative genomics analysis of Stenotrophomonas maltophilia strains from a community. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1266295
Vancouver
Li Y, Liu X, Chen L, Shen X, Wang H, Guo R, et al. Comparative genomics analysis of Stenotrophomonas maltophilia strains from a community. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1266295
BibTeX
@article{Li2023,
author = {Li, Yini and Liu, Xin and Chen, Lingzhi and Shen, Xiao and Wang, Haihong and Guo, Ruiyu and Li, Xiang and Yu, Zehui and Zhang, Xiaoli and Zhou, Yingshun and Fu, Li},
title = {Comparative genomics analysis of Stenotrophomonas maltophilia strains from a community},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1266295}
}
EUVIMED